Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roger D Weiss

Showing results (241-250 of 271) with videos related to

Pageof 28
Sort By:
The American Journal on Addictions|January 14, 2020
Impact of Medications for Opioid Use Disorder on Discharge Against Medical Advice Among People Who Inject Drugs Hospitalized for Infective EndocarditisJoji Suzuki, Diana Robinson, Matthew Mosquera, et al.
The American Journal on Addictions|February 20, 2016
A randomized, placebo-controlled proof-of-concept trial of adjunctive topiramate for alcohol use disorders in bipolar disorderLouisa G Sylvia, Alexandra K Gold, Jonathan P Stange, et al.
Drug and Alcohol Dependence|January 25, 2005
The effect of 12-step self-help group attendance and participation on drug use outcomes among cocaine-dependent patientsRoger D Weiss, Margaret L Griffin, Robert J Gallop, et al.
Experimental and Clinical Psychopharmacology|October 8, 2008
Retrospective accounts of initial subjective effects of opioids in patients treated for pain who do or do not develop opioid addiction: a pilot case-control studyCorey M Bieber, Kathrine Fernandez, David Borsook, et al.
Contemporary Clinical Trials|December 22, 2023
Effects of live-online, group mindfulness training on opioid use and anxiety during buprenorphine treatment: A comparative effectiveness RCTJoseph A Rosansky, Leah Howard, Hannah Goodman, et al.
The American Journal of Managed Care|June 4, 2013
Prescription opioid abuse: challenges and opportunities for payersNathaniel P Katz, Howard Birnbaum, Michael J Brennan, et al.
Contemporary Clinical Trials|January 22, 2025
Optimizing retention strategies for opioid use disorder pharmacotherapy: The retention phase of the CTN-0100 trial (RDD)Matisyahu Shulman, Sarah Meyers-Ohki, Patricia Novo, et al.
The American Journal on Addictions|December 5, 2022
Effects of a trauma-informed mindful recovery program on comorbid pain, anxiety, and substance use during primary care buprenorphine treatment: A proof-of-concept studyZev Schuman-Olivier, Thomas Fatkin, Timothy B Creedon, et al.
Contemporary Clinical Trials|April 24, 2024
Discontinuation of medication treatment for opioid use disorder after a successful course: The discontinuation phase of the CTN-0100 (RDD) trialMatisyahu Shulman, Scott Provost, Kaitlyn Ohrtman, et al.
Drug and Alcohol Dependence|March 31, 2015
Long-term outcomes from the National Drug Abuse Treatment Clinical Trials Network Prescription Opioid Addiction Treatment StudyRoger D Weiss, Jennifer Sharpe Potter, Margaret L Griffin, et al.
Pageof 28

Showing results (241-250 of 271) with videos related to

Sort By:
Pageof 28
The American Journal on Addictions|January 14, 2020
Impact of Medications for Opioid Use Disorder on Discharge Against Medical Advice Among People Who Inject Drugs Hospitalized for Infective EndocarditisJoji Suzuki, Diana Robinson, Matthew Mosquera, et al.
The American Journal on Addictions|February 20, 2016
A randomized, placebo-controlled proof-of-concept trial of adjunctive topiramate for alcohol use disorders in bipolar disorderLouisa G Sylvia, Alexandra K Gold, Jonathan P Stange, et al.
Drug and Alcohol Dependence|January 25, 2005
The effect of 12-step self-help group attendance and participation on drug use outcomes among cocaine-dependent patientsRoger D Weiss, Margaret L Griffin, Robert J Gallop, et al.
Experimental and Clinical Psychopharmacology|October 8, 2008
Retrospective accounts of initial subjective effects of opioids in patients treated for pain who do or do not develop opioid addiction: a pilot case-control studyCorey M Bieber, Kathrine Fernandez, David Borsook, et al.
Contemporary Clinical Trials|December 22, 2023
Effects of live-online, group mindfulness training on opioid use and anxiety during buprenorphine treatment: A comparative effectiveness RCTJoseph A Rosansky, Leah Howard, Hannah Goodman, et al.
The American Journal of Managed Care|June 4, 2013
Prescription opioid abuse: challenges and opportunities for payersNathaniel P Katz, Howard Birnbaum, Michael J Brennan, et al.
Contemporary Clinical Trials|January 22, 2025
Optimizing retention strategies for opioid use disorder pharmacotherapy: The retention phase of the CTN-0100 trial (RDD)Matisyahu Shulman, Sarah Meyers-Ohki, Patricia Novo, et al.
The American Journal on Addictions|December 5, 2022
Effects of a trauma-informed mindful recovery program on comorbid pain, anxiety, and substance use during primary care buprenorphine treatment: A proof-of-concept studyZev Schuman-Olivier, Thomas Fatkin, Timothy B Creedon, et al.
Contemporary Clinical Trials|April 24, 2024
Discontinuation of medication treatment for opioid use disorder after a successful course: The discontinuation phase of the CTN-0100 (RDD) trialMatisyahu Shulman, Scott Provost, Kaitlyn Ohrtman, et al.
Drug and Alcohol Dependence|March 31, 2015
Long-term outcomes from the National Drug Abuse Treatment Clinical Trials Network Prescription Opioid Addiction Treatment StudyRoger D Weiss, Jennifer Sharpe Potter, Margaret L Griffin, et al.
Pageof 28